Cáncer de ovario avanzado.

A phase 1 study of tazarotene in adults with advanced cancer.

British journal of cancer·2003

Antagonists of retinoic acid receptors (RARs) are potent growth inhibitors of prostate carcinoma cells.

British journal of cancer·2001

A post-marketing acceptability study in 11,685 patients of the efficacy of timolol/bendrofluazide in the management of hypertension in general practice.

The Journal of international medical research·1987

Long-term follow-up of 500 patients with mild to moderate hypertension who had successfully completed a 3-month general practice study of a timolol-bendrofluazide combination ('Prestim').

Current medical research and opinion·1987

A multi-centre general practice comparison of a fixed-dose combination of pivmecillinam plus pivampicillin with amoxycillin in respiratory tract infections.

Pharmatherapeutica·1985

A clinical comparison of pivmecillinam plus pivampicillin (Miraxid) and a triple tetracycline combination (Deteclo) in respiratory infections treated in general practice.

The Journal of international medical research·1985

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Disrupting Bacterial Quorum Sensing: A Review of Protein Families and Natural Inhibitors for Combating Resistance.

Current topics in medicinal chemistry·2026

Design, Optimization and Physicochemical Characterization of Pectin-Based Nanoparticles for In Vitro Anticancer Evaluation Against HCT116 Colon Cancer Cells.

Current pharmaceutical design·2026

Integrative bioinformatics and in vivo validation suggest a potential role of <i>Cbr4</i> in alcohol use disorder through modulation of lipid metabolism and treg cell function in the central amygdala.

Frontiers in genetics·2026

Research progress of cuproptosis, ferroptosis, apoptosis, and autophagy in knee osteoarthritis.

Frontiers in cell and developmental biology·2026

Integrating multi-omics and machine learning to uncover CCL20 as a potential regulator of the immunosuppressive microenvironment in lung adenocarcinoma.

Frontiers in immunology·2026

Uncovering cellular perturbations and key mediator communications in liver cancer using single-cell RNA sequencing.

Frontiers in immunology·2026

Videos de Experimentos Relacionados

Cáncer de ovario avanzado.

Videos de Conceptos Relacionados

A phase 1 study of tazarotene in adults with advanced cancer.

Antagonists of retinoic acid receptors (RARs) are potent growth inhibitors of prostate carcinoma cells.

A post-marketing acceptability study in 11,685 patients of the efficacy of timolol/bendrofluazide in the management of hypertension in general practice.

Long-term follow-up of 500 patients with mild to moderate hypertension who had successfully completed a 3-month general practice study of a timolol-bendrofluazide combination ('Prestim').

A multi-centre general practice comparison of a fixed-dose combination of pivmecillinam plus pivampicillin with amoxycillin in respiratory tract infections.

A clinical comparison of pivmecillinam plus pivampicillin (Miraxid) and a triple tetracycline combination (Deteclo) in respiratory infections treated in general practice.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Disrupting Bacterial Quorum Sensing: A Review of Protein Families and Natural Inhibitors for Combating Resistance.

Design, Optimization and Physicochemical Characterization of Pectin-Based Nanoparticles for In Vitro Anticancer Evaluation Against HCT116 Colon Cancer Cells.

Integrative bioinformatics and in vivo validation suggest a potential role of <i>Cbr4</i> in alcohol use disorder through modulation of lipid metabolism and treg cell function in the central amygdala.

Research progress of cuproptosis, ferroptosis, apoptosis, and autophagy in knee osteoarthritis.

Integrating multi-omics and machine learning to uncover CCL20 as a potential regulator of the immunosuppressive microenvironment in lung adenocarcinoma.

Uncovering cellular perturbations and key mediator communications in liver cancer using single-cell RNA sequencing.

Videos de Experimentos Relacionados

Cáncer de ovario avanzado.

Videos de Conceptos Relacionados

Artículos Relacionados